In recent studies that addressed the transcriptional control of steroid synthesis, a transcriptional regulating protein of 132 kDa (TReP-132) was cloned and demonstrated to regulate expression of the human P450 side chain cleavage (P450scc) gene. In the present study, we describe the cloning and characterization of the mouse orthologue of the human factor, mouse transcriptional regulating protein (mTReP-132). mTReP-132 encodes a 1216-residue protein that is 85.5% homologous to the human protein. Both factors contain characteristic motifs, namely glutamine-, proline-and acidic-rich regions. The primary structure also exhibits two zinc fingers of the C 2 H 2 subtype, suggesting that this protein has the ability to act as a DNA binding transcription factor. mTReP-132 may also be a coregulator of nuclear receptors because of two nuclear box motifs in this protein. Northern blot analysis demonstrated the expression of two transcripts of 4.4 and 7.5 kb in several tissues, but expression was clearly highest in the brain, thymus and testis of mice. In the brain, the hybridization signal was quite localized and strong in the basal ganglia, hippocampus, piriform cortex, cerebral cortex, ventromedial nucleus of the hypothalamus, and the dorsal and superior central nuclei of the raphe. Although classical steroidogenesis pathways have yet to be firmly established in the brain, expression of both mTReP-132 and P450scc provides anatomical evidence that mTReP-132 may regulate this key steroidogenic enzyme within specific regions involved in behavioral and psychiatric disorders. Moreover, the presence of both mTReP-132 and steroidogenic factor 1 (SF-1) transcripts in the ventromedial nucleus of the hypothalamus suggests a role for mTReP-132 in brain development and function. The molecular cloning and the highly specific expression of mTReP-132 across the brain further consolidate the hypothesis that this tissue is able to synthesize de novo steroids in a regionspecific manner.
Introduction
Steroidogenesis is a metabolic pathway responsible for the production of many hormones whose actions are as multiple as the tissues in which they exert their effects. 1 The cytochrome P450 side chain cleavage (P450scc) is one of the most important enzymes involved in endocrine functions and catalyzes the conversion of cholesterol to pregnenolone, which is the first step of steroidogenesis. Transcriptional regulation of P450scc in response to peptide hormones plays a key role in regulating functions of tissues expressing this enzyme. [2] [3] [4] P450scc is expressed in different steroidogenic tissues, namely the adrenal, ovary, testis, placenta, and specific regions of the rodent brain. 1, [5] [6] [7] [8] Previous studies on P450scc gene expression demonstrated the cell type specific usage of cis-acting elements and involvement of multiple trans-acting factors. Regulation of this gene therefore requires the participation of key transcription factors, co-activators and co-repressors.
The transcriptional regulating protein of 132 kDa, TReP-132, is a novel factor recently shown to interact with CREB binding protein (CBP/p300) to regulate human P450scc gene expression. 9 It is mainly expressed in thymus, adrenal cortex and testis, which are all steroidogenic tissues. However, a low expression level was also detected in several tissues including the stomach, heart, brain and placenta. Immunocytochemistry analysis has demonstrated that this protein is nuclear, which further consolidates its role as a transcription regulator. TReP-132 was demonstrated to interact with the À155/À131 element of the P450scc promoter to confer activation. It was also shown that this activation could implicate the À46 steroidogenic factor 1 (SF-1) binding site of the P450scc gene and a synergy between TReP-132 and CBP/p300 that activates its expression. The fact that TReP-132 is expressed in steroidogenic and non-steroidogenic tissues indicates that this protein is implicated in pathways other than regulation of steroidogenesis.
Neurosteroids are steroids that are synthesized de novo in the brain, and include some classical (adrenal and gonadal) steroids and some unique brain-specific steroids. Neurosteroids are thought to mediate their action through ion-gated neurotransmitter receptors, such as gamma-aminobutyric acid (A) and N-methyl-D-aspartate, rather than through classical nuclear steroid hormone receptors. 10 However, the enzymes responsible for synthesizing neurosteroids are the same as those involved in classical steroidogenesis, 11 but regulation of neurosteroidogenesis is still widely unknown and debated.
In the present study, we describe the molecular cloning of the mouse orthologue of TReP-132, mTReP-132. We have decided to clone the mouse orthologue, as it provides an essential tool to further characterize the roles of the previously cloned human TReP-132 factor. We also demonstrate here, for the first time, the unique region-specific expression of mTReP-132 in rodent brain, which may have a great impact on brain development, function and plasticity.
Materials and methods
Isolation of mTReP-132 cDNA A mouse testis cDNA expression library (Cat#ML1020b, Clontech, Palo Alto, CA, USA; kindly provided by Dr Jacques Simard, Laval University) in the phage lgt11 was screened with a probe corresponding to nucleotides 533-1036 of human TReP-132 (GenBankt accession number AF297872). After screening of approximately 4 Â 10 6 recombinants, a partial cDNA clone was isolated corresponding to nucleotides 921-2002 of TReP-132. Rapid amplification of the cDNA 5 0 end was done using a mouse testis Marathon expression bank (Clontech, Palo Alto, CA, USA) as template. The first amplification was performed using the adaptor primer 1 and the gene-specific primer H219 (5 0 -GGGTGTGCAGCACC-TGGGCCATATTGTTGACCTG-3 0 ) for 30 cycles followed by a final elongation of 10 min. Each cycle consisted of 1 min at 941C, 30 s at 941C, and 4 min at 681C; 1/10th of the PCR product was used as a template for the second amplification with the adaptor primer 2 and the gene-specific primer H43 (5 0 -GAATTCGCAGGTTTTGGTTGG-3 0 ) for 5 cycles each consisting of 30 sec at 941C and 4 min at 721C, followed by 5 cycles each consisting of 30 s at 941C and 4 min at 701C, and finally 25 cycles each consisting of 30 s at 941C and 4 min at 681C. The PCR product was cloned into the SrfI site of PCRscript SK+ (Stratagene, La Jolla, CA, USA). Both strands of the RACE-PCR product were each sequenced at least twice by dideoxy nucleotide sequencing (Amersham Pharmacia Biotech, Baie d'Urfé, Québec, Canada). A full-length clone of mTReP-132 was obtained by reverse transcription coupled to a polymerase chain reaction using total RNA from male CD-1 mouse brain isolated by the single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction.
12 cDNA synthesis was done with expand RT (Boehringer Mannheim, Germany) according to the manufacturer's instructions, using gene-specific 3 0 primers. PCR reaction was then done using the same 3 0 primer and a gene-specific 5 0 primer. Thus, a partial clone corresponding to the 3 0 region of the human protein was isolated with primer pair H286 (5 0 -CCACGTGTGCTGCTGTGCCGT TCCA-3 0 )/H281 (5 0 -GGAGCAGGAAGTCCAGGTTC-TACG GG-3 0 ), and a full-length clone was isolated using H303 (5 0 -GACATCATGGGGGACCAGCAACTG-TACAAGACC-3 0 )/H304 (5 0 -TTAGAGTTCTGTTACAC CCTGA AGCAAAACCGAATC-3 0 ) primers. cDNA fragments were then cloned in pBluescript KS+ vector (Stratagene, La Jolla, CA, USA). Both strands of the mTReP-132 cDNA were each sequenced at least twice. The sequence of the full-length clone has been deposited with the GenBankt database and has been assigned accession number AY081774.
Northern blot analysis A commercial membrane (Origene Technologies, Rockville, MD, USA) containing 2 mg of purified mRNA of each tissue was hybridized with a radio labeled probe that contains nucleotides 1289-1779 of mTReP-132. The membrane was hybridized using Ultrahyb buffer (Ambion, Austin, TX, USA) and washes were done according to the manufacturer's recommendations. The membrane was then exposed to an X-Omat film at -701C for 16 h. Stripping of the membrane was then done according to the manufacturer's recommendations, and the same blot was hybridized with a radiolabeled mouse b-actin probe provided with the membrane.
Animals
In all, 32 adult BALB/c mice (B25 g) were acclimatized to standard laboratory conditions (14 h/10 h day/night with light opened at 6 h and closed at 20 h). The mice had free access to water and food. Animal breeding and experiments were conducted according to the Canadian Council on Animal Care guidelines, as administered by the Laval University Animal Care Committee. Animals were deeply anesthetized with an intraperitoneal injection (i.p.) of 0.5 ml of a ketamine hydrochloride (80 mg/kg) and xylazine (10 mg/kg) solution and rapidly perfused transcardiacally with a solution of 0.9% saline followed by a 4% paraformaldehyde solution in a borax buffer (pH 9.5 at 41C) 0.1 M. Brains were removed from the skull and then postfixed 1-3 days and placed overnight at 41C in a 10% sucrose, 4% Complementary riboprobe (cRNA) and in situ hybridization A cDNA fragment corresponding to nucleotides 1289-1779 of mTReP-132 was inserted into the pBluescript KS+ vector (Stratagene, La Jolla, CA, USA) digested with EcoRV. The resulting construction was linearized with BamHI and HindIII for the sense and antisense riboprobe, respectively. Radiolabeled cRNA copies were synthesized by incubation of 250 ng of linearized plasmid in 6 mM MgCl 2 , 40 mM Tris (pH 7.9), 2mM spermidine, 10 mM NaCl, 10 mM dithiothreitol, 0.2 mM ATP/GTP/CTP, 200 mCi of a-
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S-UTP (Du PontFNEN; no. NEG 039H), 40 U RNasin (Promega, Madison, WI, USA), and 20 U of T7 (antisense probe) or T3 (sense probe) RNA polymerase for 60 min at 371C. Nonincorporated nucleotides were removed using the ammonium acetate method; 100 ml of DNase solution (1 ml of DNase, 5 ml of tRNA 5 mg/ml, 94 ml of a 10 mM Tris/10 mM MgCl 2 solution) was added and 10 min later a phenol/chloroform extraction was performed. cRNA was precipitated with 80 ml ammonium acetate 5 M and 500 ml absolute ethanol and incubation of 20 min on dry ice. The pellet was resuspended in 50 ml Tris 10 mM/EDTA 1 mM. Probe (10 7 cpm) was mixed into the hybridization solution (500 ml formamide, 60 ml of NaCl 5 M, 10 ml of Tris 1 M (pH 8.0), 2 ml of EDTA 0.5 M (pH 8.0), 50 ml Denhardt solution 20X, 200 ml dextran sulfate 50%, 50 ml of tRNA 10 mg/ml, 10 ml of dithiothreitol 1 M; 118 ml distilled water treated with DEPC minus volume of the probe used). This solution was incubated at 651C for 10 min before being put on slides.
Histochemical localization by hybridization of transcript was done on each sixth sections taken throughout the rostral-to-caudal extent of mouse brains (from the olfactory bulb to the medulla) and on each embryo section using 35 S-radiolabeled cRNA probes as described previously. 13 The sections were exposed to an X-ray film (Biomax, Kodak) at 41C for 18 h, defatted in xylene and soaked in nuclear emulsion NTB2 (diluted 1:1 with distilled water; Kodak). Finally, slides were exposed 7 days before being developed and counterstained with thionine (0.25%). Figure 1 ). Because this fragment had 85% identity with the human sequence of TReP-132, RACE-PCR and RT-PCR were used to obtain the remaining portions of the mouse cDNA. RACE-PCR was performed on a mouse testis cDNA library to obtain the 5 0 -end region of mTReP-132 (clone 2, Figure 1 ). Taking this fragment as the putative start site of transcription, mTReP-132 contains a 5 0 untranslated region of 389 bp, which is shorter than the human counterpart of 563 bp. To obtain the 3 0 sequence of mTReP-132, RT-PCR was performed on mouse brain total RNA from male CD-1 mice. The clone isolated (clone 3, Figure 1 ) by this method shows strong homology with the human carboxy- terminal region of the cDNA, suggesting that the coding sequences of both proteins are highly similar throughout the entire sequence. By using these strategies, information from the entire cDNA was acquired and a full-length clone was obtained by RT-PCR (clone 4, Figure 1 ).
Results

Isolation
Primary structure of mTReP-132
The open reading frame of mTReP-132 is comprised of 3648 nucleotides, which encode a polypeptide of 1216 residues with a predicted molecular mass of 134 kDa. Analysis of the mTReP-132 primary sequence reveals the presence of functional motifs characteristic of a DNA binding factor, namely two putative C 2 H 2 zinc finger motifs, which in other proteins have been shown to be involved in protein interaction and DNA binding. The region between residues 262 and 339 contains several glutamine-rich sequences, the region between residues 551-579 and 991-1006 contains many prolines, and the region between amino acids 961 and 986 contains 16 glutamate residues, all of which have been found in other proteins to be involved in transcriptional activation ( Figure 2 ). Two nuclear receptor box sequences LRQLL and LEMLL are also found, which match the canonical LXXLL sequence that has been described to be important for interactions with nuclear receptors. 14 The two TReP-132 sequences share 85.5% homology. All functional motifs present in mouse TReP-132 are also found in human TReP-132 in a conserved manner. A consensus polyadenylation signal AATAAA is found 202 bp downstream of the STOP codon and corresponds to an identical signal in the human cDNA.
Mouse TReP-132 mRNA is expressed mainly in brain, testis, fetal adrenals and thymus Human TReP-132 has previously been shown to be expressed as two transcripts of 4.4 and 7.5 kb mainly in the thymus, testis and adrenal cortex. 9 To determine whether tissue distribution of mTReP-132 was similar, Northern blot analysis was performed using a 490 bp cDNA probe corresponding to nucleotides 1289-1779 of mTReP-132 (Figure 3a) . In human tissues, two transcripts of 4.4 and 7.5 kb were detected in most of the samples examined except for the muscle, small intestine and spleen. However, it is clear that the mouse brain expresses the highest levels of both transcripts. Strong expression of both transcripts is also detected in kidney and lung. Additionally, testis and thymus express high levels of the smaller transcript. These results were confirmed by in situ hybridization of 15.5 days post-coitum mouse embryos (Figure 3b ). High expression is detected in brain, lung, fetal adrenal, thymus and kidney. In addition to these tissues, transcript was also detected in spinal cord and sensitive regions, namely the retina and snout (Figure 3b) .
Distribution of the gene encoding mTReP-132 in the brain As shown by Northern blot analysis, mTReP-132 mRNA is strongly expressed in the brain. In situ hybridization was therefore used to determine the exact pattern of expression of mTReP-132 transcript in this organ using a cRNA probe containing the same region used for Northern blot analysis. A very specific and localized pattern was found in the mouse brain ( Figures 4 and 5) ; the gene encoding mTReP-132 was not detected in the septal region that includes the On the other hand, a moderate to high hybridization signal was detected across the basal ganglia, especially in the caudate putamen (CPu) and the fundus of the striatum. The piriform area (PIR) exhibited a robust signal for the gene encoding the nuclear factor, whereas a lower but strong expression was found over numerous layers of the cerebral cortex (CeC). The signal in layer #2 (CeC2) was quite intense, in particular over the cells adjacent to the layer #1 of the retrosplenial area, ventral part.
Of interest is the strong expression of mTReP-132 transcript in the hippocampal formation (Hip). The pyramidal cell layer of the CA1 and the molecular mTReP-132 regional expression in the mouse brain Y Duguay et al layer of the dentate gyrus (DG) exhibited a strong hybridization signal, which was lower in the CA2 and CA3 (Figure 5a and b) . A low and diffused expression pattern was detected across the hypothalamus, except for the ventromedial nucleus of the hypothalamus (VMH) that displayed a localized and strong signal (Figure 5e and f). The thalamic area was essentially devoid of mTReP-132-expressing neurons; a low expression level was found only over the cells lining the reticular nucleus of the thalamus (RT), the paraventricular nucleus of the thalamus and few isolated subthalamic regions. mTReP-132 transcript was, on the other hand, widely expressed throughout the tegmentum, especially within the mammillary nuclei (MM), periaqueductal gray (PAG), lateral geniculate complex (LG), zona incerta (ZI), magnocellular nucleus of the posterior commissure (MCP), anterior pretectal nucleus, ventral part (APTv), and the anterior pretectal nucleus, dorsal part (APTd). Caudally, mTReP-132 mRNA levels were not very abundant, although a localized and strong hybridization signal was found in the dorsal nucleus of the raphe (DR) and superior central nucleus of the raphe, medial part (CSm, Figure 5i and j). These regions play an important role in the control of serotonergic systems in the CNS. The cerebellar cortex (Cer) had silver grains that corresponded to background level, and very few mTReP-132-expressing cells were detected in the pons and medulla. This was the case for the area postrema (AP), nucleus of the solitary tract (NTS), the spinal nucleus of the trigeminal, caudal part (SPVC) and medullary reticular nucleus (MDRN) that exhibited a low but positive signal, for the mRNA encoding this novel transcription factor. Adjacent sections hybridized with the sense probe failed to display any positive signal, providing evidence that the probe used was specific for hybridizing mTReP-132 cRNA (Figure 4 , right column).
Note that the distribution and intensity of the signal remain quite similar across the 32 mouse brains hybridized with the antisense probe.
Discussion
Recent work in our laboratory has led to the molecular cloning of TReP-132, a nuclear factor implicated in the regulation of the cytochrome P450scc gene. 9 It was also demonstrated that TReP-132 interacts with p300/CBP to regulate P450scc gene expression. P450scc catalyzes the important first step in steroidogenesis, which implies a role for TReP-132 in steroid synthesis regulation. Although the thymus, testis and adrenal cortex were the main tissues expressing TReP-132, expression was also found in tissues that are not primarily steroidogenic, such as the kidney, lung and brain. This indicates that TReP-132 may have a larger role than regulating steroid synthesis or modulating target genes involved in steroid synthesis. The mouse orthologue of TReP-132 was therefore cloned to better understand the potential role of this novel regulating protein and to determine its exact expression pattern.
To clone the mouse orthologue of TReP-132, a mouse testis cDNA library was screened and a single clone was isolated. Subsequent PCR experiments allowed the isolation of a full-length clone of mTReP-132. Nucleotide sequence analysis of the mTReP-132 cDNA clone revealed an open reading frame of 3648 bp preceded by a 5 0 untranslated region (5 0 -UTR) of 389 bp. Analysis of sequence homology between both human and mouse TReP-132 shows significantly less homology in the sequence upstream of the predicted human initiator AUG, thus suggesting that the same AUG is probably used to initiate translation of the mouse transcript. Moreover, analysis of the nucleotide context surrounding the pre- Figure 4 Expression of mTReP-132 in the mouse brain. These rostro-caudal coronal sections (20 mm) exhibit a positive signal on dark-field photomicrographs of dipped NTB-2 emulsion slides. Only the sections hybridized with the antisense probe displayed a positive signal (agglomeration of silver grains), while those hybridized with the sense probe failed to show any convincing signal (right column). AHN, anterior hypothalamic nucleus; AP, area postrema; APTv, anterior pretectal nucleus, ventral part; APTd, anterior pretectal nucleus, dorsal part; BLA, basolateral nucleus of the amygdala; BLA, basomedial nucleus of the amygdala; CA1, field CA1, Ammon's horn of hippocampus; CA2, field CA2, Ammon's horn of hippocampus; CA3, field CA3, Ammon's horn of hippocampus; cc, corpus callosum; CeC, cerebral cortex; CeC2, cerebral cortex, layer # 2; Cer, cerebellar cortex; CPu, caudate putamen; CSm, superior central nucleus of the raphe, medial part; cst, corticospinal tract; DG, dentate gyrus; DR, dorsal nucleus of the raphe; f, columns of the fornix; Hip, hippocampus; IC, inferior colliculus; LG, lateral geniculate complex; LHA, lateral hypothalamic area; LSv, lateral septal nucleus, ventral part; LSi, lateral septal nucleus, intermediate part; MCP, magnocellular nucleus of the posterior commissure; MDRN, medullary reticular nucleus; MEA, medial nucleus of the amygdala; MGv, medial geniculate complex, ventral part; MM, mammillary nucleus; MPO, medial preoptic area; MS, medial septal nucleus; NDB, nucleus of the diagonal band; NTS, nucleus of the solitary tract; PAG, periaqueductal gray; PIR, piriform area; PG, pontine gray; PVN, paraventricular nucleus of the hypothalamus; RE, nucleus reuniens; RT, reticular nucleus of the thalamus; SC, superior colliculus; sct, spinocerebellar tracts; sptV, spinal tract of the trigeminal nerve; SPVC, spinal nucleus of the trigeminal, caudal part; SPVO, spinal nucleus of the trigeminal, oral part; 3rd, third ventricle; V4, fourth ventricle; VCO, ventral cochlear nucleus; VDB, nucleus of the vertical limb of the diagonal band; VMH, ventromedial nucleus of the hypothalamus; VN, trigeminal nerve; ZI, zona incerta. dicted mouse initiator AUG (GAGGACAUCAUGG) shows homology with the sequence GCCGCC(A/ G)CCAUGG defined by Kozak. 15 Analysis of the primary sequence of mTReP-132 reveals the presence of many structural motifs, which are conservatively present in the human sequence of TReP-132. The region from amino acids 262 to 339 contains many glutamine residues that have been found in several nuclear factors, including Sp1 16 and Oct-1 17, to confer activation of transcription. The region between amino acids 551 and 579 is proline rich, which has been shown to form an important activation domain in CTF 18 and Oct-2. 19 Finally, the region between 961 and 1006 of mTReP-132 contains acidic residues and is rich in prolines. Such a domain is shown to be important for p53 function. 20 Each of these regions are conserved between the human and mouse TReP proteins. So, it would be tempting to speculate that the functions of the TReP-132 and mTReP-132 proteins are the same in mice and humans, considering that all of the functional motifs are conserved. However, functional studies of mTReP-132 will be necessary to assert this hypothesis.
As for the human sequence, the primary sequence of mTReP-132 reveals the presence of three zinc fingers. However, the second zinc finger motif contains an insert of 36 bp, which adds 12 amino acids in the middle of the consensus sequence. Interestingly, this insert is also present in a recently described human isoform of TReP-132. The presence of this insertion on the functional significance of the second zinc finger sequence has not been assessed, and further studies will be required to evaluate the importance of each zinc finger structure on the activity of the protein. The mouse clone therefore contains all the functional domains of the different isoforms of TReP-132 characterized so far. As mentioned, distinct isoforms of the human and mouse transcripts were identified by Northern blot analysis. The presence of the two TReP-132 transcripts was partly attributed to a longer 3 0 -end for the 7.5 kb transcript, 9 which may also explain the two mTReP-132 transcripts. Additionally, Mauch and colleagues have Aeported two isoforms of TReP-132, RAPA-1 and RAPA-2, which lack nucleotides 661-907 and 2200-2448 (GenBankt accession number AJ277275 and AJ277276). These isoforms represent variations of the human sequence that are identical to those found in the murine clone. This further indicates that different isoforms of this gene are present in both species. The region from nucleotides 2200 to 2448 is a proline-rich region involved in protein-protein interactions. 18, 19 RAPA-2 also contains a 36 bp insert in the second zinc finger putative motif. Interestingly, this insert is also found in the mTReP-132 sequence. This particular isoform clearly corresponds to an isoform possessing a nonconsensus zinc finger motif. This characteristic may yield TReP-132 and mTReP-132 to modulate gene expression by altering the DNA binding capacity of the protein.
Further studies will be required to assess the exact roles of each mTReP-132 and TReP-132 isoform. Moreover, specific expression analysis will be required to determine the tissue distribution of each isoform.
It is interesting to note that the signal for the gene encoding TReP-132 is localized in the same human and murine tissues with one exemption, the brain. While TReP-132 transcript levels are high in the mouse brain, only low levels were previously found in the human brain. 9 The human RNA was nevertheless extracted from an unknown region of the brain and it is possible that this region is lacking in TReP-132 mRNA due to the highly localized hybridization signal. Extracting RNA from human brain is also rarely performed in optiual conditions and degradation of TReP-132 mRNA may explain the low expression levels.
The sequence of mTReP-132 reveals the presence of two nuclear box motifs LRQLL and LEMLL, which are involved in interaction of proteins with nuclear receptors.
14 Preliminary data in our laboratory suggest that TReP-132 could interact with the nuclear receptor SF-1 (F Gizard et al, 2002) . 28 SF-1 is not only involved in the regulation of steroidogenesis, but mTReP-132 regional expression in the mouse brain Y Duguay et al also gonadal development 21 and formation of the VMH. Indeed, mice lacking SF-1 secondary to targeted disruption of the Ftz-F1 gene had grossly impaired VMH structure. 22 Interestingly, SF-1 is strongly expressed in the VMH as well as along the pyramidal cell layer of the CA1-CA3 of the rodent brain. 23 These regions are among those that exhibited a positive hybridization signal for mTReP-132 mRNA, which provides the anatomical link that it may be a factor associated with SF-1 functions, at least in the VMH and hippocampal formation.
Although mTReP-132 mRNA was already strongly expressed in the brain at 15.5 days post-coitum, a complete ontogenetic study will be necessary to demonstrate the expression levels at different periods of the mouse development. Generating TReP-132-deficient mice will also be crucial to determine whether this transcription factor is involved in adrenal and VMH development, such as in the case of SF-1. 23 Co-expression of mTReP-132 and SF-1 in the VMH nevertheless suggests that the two proteins may have the ability to interact to regulate gene expression in this specific region of the brain. This concept is further reinforced by the presence of P450scc in regions that exhibited a positive hybridization signal for the gene encoding mTReP-132 and SF-1.
5 mTReP-132 and P450scc are also found in areas known to be important for neurosteroidogenesis, among which is the hippocampal formation. TReP-132 interacts with CBP/p300 to modulate P450scc gene transcription and CBP is present in hippocampal neurons. 24 These data lead to the conclusion that mTReP-132 may act in concert with SF-1 and/or CBP/p300 to regulate P450scc expression in a region/nucleus-specific manner in the brain.
We have yet to find the exact role of mTReP-132 in the CNS, but it is tempting to propose that it plays a role in neuronal plasticity and memory. There is a strong hybridization signal over the pyramidal cell layer of the CA1 and molecular layer of the DG, and accumulating evidence supports the concept that neurosteroids play a major role in cognitive processes, such as learning and memory (for a review, see Baulieu 25 ). mTReP-132 mRNA levels were not very abundant in the brainstem, but a localized and strong hybridization signal was found in the dorsal nucleus of the raphe and medial part of the superior central nucleus of the raphe. These regions play an important role in the control of serotonergic systems in the CNS that are involved in a wide variety of behaviors and major affective disorders. Expression of mTReP-132 in specific regions of the raphe is of particular interest in this regard because neuroactive steroids have been proposed to play a role in the treatment of psychiatric disorders, such as depression. 26 Selective serotonin reuptake inhibitors also have the ability to alter the activity of neurosteroidogenic enzymes.
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P450scc was found in sensory structures of the peripheral nervous system during rodent embryogenesis, 7 which is also the case for mTReP-132 in the snout and retina of embryos. This suggests a possible function for mTReP-132 and P450scc in coordinating environmental cues and behavior as well as the development and organization of the nervous system. Once again, mice lacking mTReP-132 are needed to establish firmly the exact role of this transcription factor in the CNS. The molecular cloning of mTReP-132 has allowed us to determine the specific expression pattern of this transcriptional regulating protein that may play key roles in both development and endogenous production of neurosteroids in key regions involved in behavioral and psychiatric disorders.
